These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 25872387)
21. [Structural changes of the retina and corpus vitreum in the model of proliferative vitreoretinopathy in alloxan diabetes]. Logvinov SV; Krivosheina OI; Zapuskalov IV; Varakuta EIu; Potapov AV Morfologiia; 2005; 127(3):34-7. PubMed ID: 16381309 [TBL] [Abstract][Full Text] [Related]
23. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR. Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294 [TBL] [Abstract][Full Text] [Related]
24. [Intraocular surgery for secondary retinal detachment in proliferative vitreoretinopathy]. Pournaras CJ; Donati G Klin Monbl Augenheilkd; 1995 May; 206(5):339-42. PubMed ID: 7609381 [TBL] [Abstract][Full Text] [Related]
25. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy. Johnsen EO; Frøen RC; Albert R; Omdal BK; Sarang Z; Berta A; Nicolaissen B; Petrovski G; Moe MC Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407 [TBL] [Abstract][Full Text] [Related]
26. Inflammation measurement and immunocharacterization of cell proliferation in an experimental model of proliferative vitreoretinopathy. Baudouin C; Khosravi E; Pisella PJ; Ettaiche M; Elena PP Ophthalmic Res; 1998; 30(6):340-50. PubMed ID: 9731115 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. Er H; Turkoz Y; Mizrak B; Parlakpinar H Ophthalmologica; 2006; 220(1):17-22. PubMed ID: 16374044 [TBL] [Abstract][Full Text] [Related]
28. The Effects of Ozurdex® (Dexamethasone Intravitreal Implant) on Experimental Proliferative Vitreoretinopathy. Kuo HK; Chen YH; Wu PC; Kuo YH Ophthalmologica; 2015; 233(3-4):198-203. PubMed ID: 25721986 [TBL] [Abstract][Full Text] [Related]
29. The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathy. Ozerdem U; Mach-Hofacre B; Keefe K; Pham T; Soules K; Appelt K; Freeman WR Ophthalmic Res; 2001; 33(1):20-3. PubMed ID: 11114600 [TBL] [Abstract][Full Text] [Related]
30. The role of retinotomy in an experimental rabbit model of proliferative vitreoretinopathy. Goldaracena MB; Garcia-Layana A; Pastor JC; Saornil MA; de la Fuente F; Gayoso MJ Curr Eye Res; 1997 May; 16(5):422-7. PubMed ID: 9154379 [TBL] [Abstract][Full Text] [Related]
31. Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy. Turkoz Y; Er H; Borazan M; Yilmaz H; Mizrak B; Parlakpinar H; Cigremis Y Mediators Inflamm; 2004 Apr; 13(2):127-30. PubMed ID: 15203555 [TBL] [Abstract][Full Text] [Related]
32. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy. Nakagawa M; Refojo MF; Marin JF; Doi M; Tolentino FI Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628 [TBL] [Abstract][Full Text] [Related]
33. Pap testing and direct immunofluorescence for Chlamydia trachomatis infection in pregnant women. Kajaia D; Merabishvili N; Burkadze G Georgian Med News; 2006 Feb; (131):27-30. PubMed ID: 16575125 [TBL] [Abstract][Full Text] [Related]
34. [Melfalan in the treatment of proliferative vitreoretinopathy (experimental study)]. Khoroshilova-Maslova IP; Leparskaya NL; Alpeeva EV; Voroteliak EA Vestn Oftalmol; 2020; 136(4):19-25. PubMed ID: 32779453 [TBL] [Abstract][Full Text] [Related]
36. The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR). Nassar K; Lüke J; Lüke M; Kamal M; Abd El-Nabi E; Soliman M; Rohrbach M; Grisanti S Graefes Arch Clin Exp Ophthalmol; 2011 Nov; 249(11):1649-60. PubMed ID: 21735240 [TBL] [Abstract][Full Text] [Related]
37. Frequency of ocular chlamydial infection among young adults. Smith KD; Tokarewicz AC; Schieven BC Can J Ophthalmol; 1992 Feb; 27(1):16-8. PubMed ID: 1555129 [TBL] [Abstract][Full Text] [Related]
38. Attenuated glial reaction in experimental proliferative vitreoretinopathy treated with liposomal doxorubicin. Kuo HK; Chen YH; Wu PC; Wu YC; Huang F; Kuo CW; Lo LH; Shiea J Invest Ophthalmol Vis Sci; 2012 Jun; 53(6):3167-74. PubMed ID: 22491400 [TBL] [Abstract][Full Text] [Related]
39. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy. Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843 [TBL] [Abstract][Full Text] [Related]